|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 妊娠期高血压疾病对远期心血管病的影响显示文摘对妇女妊娠期高血压疾病(hypertensive disorder of pregnancy,HDP)史的研究,可能有助于改善动脉粥样硬化性心血管病的风险评估。但是,有HDP既往史的中年无症状妇女在未来患心血管病的风险仍未知。该研究旨在探讨有或无HDP既往史的中年女性心血管病的远期发病率。纳入标准:在前瞻性、观察性英国生物资料库中,纳入40~69岁并至少有一活产的英国妇女,对其中一亚组妇女进行了无创性动脉硬度测量。 | 周卫(译) 叶鹏(摘、审校) Honigberg MC Zekavat SM Aragam K Klarin D Bhatt DL Scott NS Peloso GM Natarajan P | 2020 | 中华高血压杂志2020，28，2： | 6 |
| 2 | 全球动脉粥样硬化血栓形成门诊患者中心血管危险因素的患病率、认知和治疗显示文摘Context: Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has characterized the atherosclerosis risk factor profile or treatment intensity of individuals with atherothrombosis. Objective: To determine whether atherosclerosis risk factor prevalence and treatment would demonstrate comparable patterns in many countries around the world. Design, Setting, and Participants: The Reduction of Atherothrombosis for Continued Health(REACH) Registry collected data on atherosclerosis risk factors and treatment. A total of 67 888 patients aged 45 years or older from 5473 physician practices in 44 countries had either established arterial disease(coronary artery disease[CAD], n=40 258; cerebrovascular disease, n=18843; peripheral arterial disease, n=8273) or 3 or more risk factors for atherothrombosis(n=12 389) between 2003 and 2004. Main Outcome Measures: Baseline prevalence of atherosclerosis risk factors, medication use, and degree of risk factor control. Results: Atherothrombotic patients throughout the world had similar risk factor profiles: a high proportion with hypertension(81.8% ), hypercholesterolemia(72.4% ), and diabetes(44.3% ). The prevalence of overweight(39.8% ), obesity(26.6% ), and morbid obesity(3.6% ) were similar in most geographic locales, but was highest in North America(overweight: 37.1% , obese: 36.5% , and morbidly obese: 5.8% ; P< .001 vs other regions). Patients were generally undertreated with statins(69.4% overall; range: 56.4% for cerebrovascular disease to 76.2% for CAD), antiplatelet agents(78.6% overall; range: 53.9% for ≥ 3 risk factors to 85.6% for CAD), and other evidence-based risk reduction therapies. Current tobacco use in patients with established vascular disease was substantial(14.4% ). Undertreated hypertension(50.0% with elevated blood pressure at baseline), undiagnosed hyperglycemia(4.9% ), and impaired fasting glucose(36.5% in those not known to be diabetic) were common. Among those with symptomatic atherothrombosis, 15.9% had symptomatic polyvascular disease. Conclusion: This large, international, contemporary database shows that classic cardiovascular risk factors are consistent and common but are largely undertreated and undercontrolled in many regions of the world. | Bhatt D.L Gabriel Steg P Magnus Ohman E. 黄浙勇 | 2006 | 世界核心医学期刊文摘(心脏病学分册)2006，2，5： | 5 |
| 3 | Eu(Ⅲ) Indirect Probe to Investigate Interaction of DOPA (3,4,Di-Hydroxyphenylalanine) and Dopamine (3,4-Dihydroxy Phenyl Ethyl Amine) Using Electrochemical Methods显示文摘Eu(Ⅲ) can be utilized as an indirect electrochemical probe to investigate the interaction of bio-molecules such as DOPA and Dopamine with Ca(Ⅱ) in vitro. The interaction of DOPA and Dopamine with Eu(Ⅲ)-Eu(Ⅱ) redox pair was investigated by electrochemical techniques. Both the neurotransmitters are structurally related and undergo interaction with Eu(Ⅲ). Eu(Ⅲ) coordinates with DOPA and Dopamine through five-member chelate rings via carboxylic oxygen and amino nitrogen. The electrode kinetic parameters viz, transfer coefficient (α_ na ), diffusion coefficient (D), forward heterogeneous rate constant (k^0_ fh ) were evaluated for Eu(Ⅲ)-DOPA/Eu(Ⅲ)-Dopamine. The results obtained were used to investigate the nature of interaction of Eu(Ⅲ) with multi-donor biomolecules. The possible mechanism was also proposed. [BT(4+1] | Prashant N Bhatt Trupti V Pathak Jignasu P Mehta G.Ramchandraiha | 2006 | Journal of Rare Earths2006，24，6： | 3 |
| 4 | Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention显示文摘 | Chan A W Bhatt D L Chew D P | | 0，，： | 1 |
| 5 | Use of intensive lipidlowering therapy in parients hospitalized with acute coronary syndrome:an analysis of 65,396 hospitalizations from 344 hospital participating in Get With The Guidelines(GWTG)显示文摘 | Javed U Deedwania P C Bhatt D L | | 0，，02： | 1 |
| 6 | Nutritional values of some commercial edible bamboo species of the North Eastern Himalayan region,India显示文摘 | BHATT B P SINGH K SINGH A | | 0，，02： | 1 |
| 7 | Synthesis and in vivo antitumor activity of poly (L-glutamic acid) conjugates of 20 (S)-camptothecin显示文摘 | BHATT R VRIES P D TULINSKY J | 2003 | J Med Chem2003，46，1： | 1 |
| 8 | Cardiovascular disease and meno- pause显示文摘 | Dosi R Bhatt N Shah P | 2014 | J Clin Diagn Res2014，8，2： | 1 |
| 9 | 1-alpha-tocopheryl acetate (vitamin E):a long term toxicity and carcinogenicity study in rats显示文摘 | Wheldon G H Bhatt A Keller P | 1983 | International Journal for Vitamin and Nutrition Research1983，53，： | 1 |
| 10 | The clopidogrel in unstable angina to prevent recurrent events(CURE) study: to what extent should the results be generalizable显示文摘 | Gerschutz G P Bhatt D L | 2003 | Am Heart J2003，145，： | 1 |
| 11 | Nonin- vasive positive pressure ventilation in subjects with stable COPD 显示文摘 | Bhatt Surya P Peterson Michael W Wilson Jeffrey S | 2013 | Int J Chron Obstruct Pulmon Dis2013，8，： | 1 |
| 12 | Incremental prognostic Value of elerated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention显示文摘 | CHEW D P BHATT D I ROBBINS M A | 2001 | Circulation2001，104，6： | 1 |
| 13 | 3-Hydroxyleukotriene B4 (3-OH-LTB4) : total synthesis and stereochemical assignment显示文摘 | Bhatt R K Chauhan K Wheelan P etal | 1994 | Journal of the American Chemical Society1994，116，12： | 1 |
| 14 | Magnetic-fluid-based smart centrifugal switch显示文摘 | Bhatt R P | 2002 | Journal of Magnetism and Magnetic Materials2002，252，： | 1 |
| 15 | Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure显示文摘 | Shakarjian M P Bhatt P Gordon M K | 2006 | Appl Toxicol2006，26，3： | 1 |
| 16 | De- sign of frequency-coded waveforms for target detec- tion 显示文摘 | Bhatt T D Rajan E G Somasekhar Rao P V D | 2008 | IET radar sonar navigation2008，10，3： | 1 |
| 17 | Incomplete Inhibition of Thromboxane Biosynthesis by Acetylsalicylic Acid: Determinants and Effect on Cardiovascular Risk显示文摘 | John W. Eikelboom Graeme J. Hankey Jim Thom Deepak L. Bhatt P Gabriel Steg Gilles Montalescot S Claiborne Johnston Steven R. Steinhubl Koon-Hou Mak J Donald Easton Christian Hamm Tingfei Hu Keith A.A. Fox Eric J. Topol | 2008 | Circulation2008，，17： | 1 |
| 18 | On the corrosion behavior of magnesiumand its alloys using electrochemical techniques显示文摘 | Udhayan R Bhatt D P | 1996 | Journal ofPower Sources1996，63，1： | 1 |
| 19 | Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reaction protein显示文摘 | Chew D P Bhatt D L Robbins MA | 2001 | Am J Cardiol2001，88，： | 1 |
| 20 | Conjugation of camptothecins to poly-(L-glutamic acid) 显示文摘 | Singer J W Devries P Bhatt R | 2000 | Ann Nat Y Acad Sci2000，922，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员